Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy

Epilepsia

Volumn 57, Issue 5, 2016, Pages 823-831

  Wright, Sukhvir ^a   Geerts, Ada T ^b   Jol Van Der Zijde, Cornelia Maria ^c   Jacobson, Leslie ^a   Lang, Bethan ^a   Waters, Patrick ^a   Van Tol, Maarten J D ^c   Stroink, Hans ^d   Neuteboom, Rinze F ^b   Brouwer, Oebele F ^e   Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Canisius Hospital   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autoantibodies; NMDA receptor; Pediatric epilepsy; Voltage gated potassium channel complex

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID RECEPTOR; ANTICONVULSIVE AGENT; AXONIN 1; CELL ANTIBODY; CONTACTIN ASSOCIATED PROTEIN LIKE 2; GLUTAMATE DECARBOXYLASE; LEUCINE RICH GLIOMA INACTIVATED 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; AUTOANTIBODY; CNTNAP2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN;

AUTISM; CELL SURFACE; CHILD; CHILDHOOD ABSENCE EPILEPSY; CHILDHOOD DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; COMORBIDITY; CONTROLLED STUDY; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; IMMUNOTHERAPY; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; NERVE CELL; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SEX RATIO; TREATMENT RESPONSE; ADOLESCENT; BLOOD; CLASSIFICATION; COHORT ANALYSIS; IMMUNOLOGY; INFANT; NETHERLANDS; NEWBORN;

ADOLESCENT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONTACTIN 2; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NETHERLANDS; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84966588550     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13356     Document Type: Review

References (30)

1. Irani SR, Gelfand JM, Al-Diwani A, et al., Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 2014; 76: 168-184.
2. Leypoldt F, Armangue T, Dalmau J,. Autoimmune encephalopathies. Ann N Y Acad Sci 2014; 1338: 94-114.
3. Irani SR, Alexander S, Waters P, et al., Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748.
4. Lai M, Huijbers MG, Lancaster E, et al., Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9: 776-785.
5. Irani SR, Bera K, Waters P, et al., N-methyl- d -aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133: 1655-1667.
6. Dalmau J, Gleichman AJ, Hughes EG, et al., Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
7. Irani SR, Michell AW, Lang B, et al., Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69: 892-900.
8. Irani SR, Stagg CJ, Schott JM, et al., Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013; 136: 3151-3162.
9. Majoie HJ, de Baets M, Renier W, et al., Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 2006; 71: 135-141.
10. McKnight K, Jiang Y, Hart Y, et al., Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005; 65: 1730-1736.
11. Brenner T, Sills GJ, Hart Y, et al., Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013; 54: 1028-1035.
12. Suleiman J, Wright S, Gill D, et al., Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 2013; 54: 2091-2100.
13. Quek AM, Britton JW, McKeon A, et al., Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012; 69: 582-593.
14. Bien CG,. Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: review of the literature and suggestions for clinical management. Epilepsia 2013; 54 (Suppl. 2): 48-55.
15. Arts WF, Geerts AT, Brouwer OF, et al., The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia 1999; 40: 726-734.
16. Arts WF, Brouwer OF, Peters AC, et al., Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain 2004; 127: 1774-1784.
17. Hauser WA, Anderson VE, Loewenson RB, McRoberts SM,. Seizure recurrence after a first unprovoked seizure. N Engl J Med 1982; 307: 522-528.
18. Callenbach PM, Jol-Van Der Zijde CM, Geerts AT, et al., Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol 2003; 132: 144-151.
19. Stroink H, Brouwer OF, Arts WF, et al., The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. Dutch study of epilepsy in childhood. J Neurol Neurosurg Psychiatry 1998; 64: 595-600.
20. Geerts A, Brouwer O, Stroink H, et al., Onset of intractability and its course over time: the Dutch study of epilepsy in childhood. Epilepsia 2012; 53: 741-751.
21. Paterson RW, Zandi MS, Armstrong R, et al., Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 2014; 85: 625-630.
22. Hacohen Y, Singh R, Rossi M, et al., Clinical relevance of voltage-gated potassium channel-complex antibodies in children. Neurology 2015; 85: 967-975.
23. Beaudoin GM III, Lee SH, Singh D, et al., Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat Protoc 2012; 7: 1741-1754.
24. Kaech S, Banker G,. Culturing hippocampal neurons. Nat Protoc 2006; 1: 2406-2415.
25. Zandi MS, Paterson RW, Ellul MA, et al., Clinical relevance of serum antibodies to extracellular N-methyl- d -aspartate receptor epitopes. J Neurol Neurosurg Psychiatry 2015; 86: 708-713.
26. Hacohen Y, Wright S, Waters P, et al., Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013; 84: 748-755.
27. Ramanathan S, Wong CH, Rahman Z, et al., Myoclonic status epilepticus as a presentation of caspr2 antibody-associated autoimmune encephalitis. Epileptic Disord 2014; 16: 477-481.
28. Hacohen Y, Deiva K, Pettingill P, et al., N-methyl- d -aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2014; 29: 90-96.
29. Mohammad SS, Sinclair K, Pillai S, et al., Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl- d -aspartate receptor or dopamine-2 receptor. Mov Disord 2014; 29: 117-122.
30. Hegde M, Lowenstein DH,. The search for circulating epilepsy biomarkers. Biomark Med 2014; 8: 413-427.